The regulatory medical writing firm is being acknowledged by industry for outstanding service and specialized commitment to its biotechnology and pharmaceutical partners.
The regulatory medical writing firm is being acknowledged by industry for outstanding service and specialized commitment to its biotechnology and pharmaceutical partners.
SAN DIEGO, Calif., July 10, 2023 (NEWSWIRE) – Aroga Biosciences, a regulatory medical writing and submissions firm, announces today it has been named in Life Sciences Review’s Top 10 Medical Writing Services Providers 2023 in the April 2023 special publication, Medical Writer’s Edition.
Founded by Krithi Bindal, M.S., Ph.D., M.B.A., Aroga Biosciences seeks to alleviate the burden of regulatory demands by providing a comprehensive suite of scientifically sound support, ranging from clinical study reports and NDAs/BLAs to risk-management and other safety documents, as well as nonclinical study reports and CMC summaries. Additionally, Dr. Bindal’s team supports clients in QC work, including document control, formatting, and submission planning.
After many years in the regulatory-writing arena, Dr. Bindal was personally motivated to form Aroga Biosciences after experiencing firsthand the importance of timely therapeutics being made available to patients. By recognizing how regulatory environments can make or break the progress of a new therapy, she has organized Aroga Biosciences’ team in such a way to help bring both efficiency and accuracy to the regulatory process, allowing clients to move therapies through official review more seamlessly.
“Our motto at Aroga Biosciences is ‘strength from science.’ It drives our passion for delivering high-quality regulatory writing services,” says Dr. Bindal. Backing up this claim is the team behind the work, a core group of regulatory experts with M.S., Ph.D. and Pharm.D. degrees who are specifically and specially trained for the rigors and technical nature of regulatory writing. With this rigor comes a tight process, and a keen understanding of resourcing, regulatory, and submission-planning strategies.
Team members are equipped to support and complement one another within the process and are proud of the culture they exhibit in the outcomes of their work. A hallmark of their collaborative spirit comes in the form of consistently positive client feedback. “We had the pleasure of teaming up with Krithi and her team at Aroga while working on an important regulatory submission. They demonstrated deep knowledge, professionalism, flexibility, and dedication. Things went as planned, and the objectives were accomplished under aggressive timelines. We look forward to working with [Aroga] again,” says a biotech COO.
Aroga Biosciences is a trusted provider of regulatory writing support to clients in the United States, Asia-Pacific, and European regions.
About Aroga Biosciences
Aroga Biosciences is a firm that provides highly experienced regulatory writing services for biotech and pharmaceutical projects. We are a team of scientists with extensive regulatory and medical writing experience in a broad range of therapeutic areas. Our mission is to provide high-quality deliverables with flexibility and adherence to regulatory standards.
To learn more about Aroga Biosciences, visit https://www.arogabio.com. Inquiries into Aroga Biosciences’ service offerings and client partnership opportunities can be made to info@arogabio.com.
Contact
Krithi Bindal, M.S., Ph.D., M.B.A.
President and Principal
+1 858-925-6145
kbindal@arogabio.com
